SFP
UTHR icon

Santa Fe Partners’s United Therapeutics UTHR Stock Holding History

Santa Fe Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,135
Closed -$2.06M – 305
2015
Q4 		$2.06M Buy
+13,135
New +$1.91M 0.34% 112
2015
Q3 		– Sell
-11,211
Closed -$1.95M – 587
2015
Q2 		$1.95M Buy
+11,211
New +$2.02M 0.27% 148
2014
Q3 		– Sell
-16,110
Closed -$1.43M – 605
2014
Q2 		$1.43M Sell
16,110
-17,708
-52% -$1.7M 0.21% 201
2014
Q1 		$3.18M Buy
+33,818
New +$3.46M 0.45% 76

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Santa Fe Partners's UTHR Position: Q1 2016 in Review

Santa Fe Partners sold out of United Therapeutics (UTHR) in Q1 2016, closing a stake of 13,135 shares — an estimated $2.06M sold.

Santa Fe Partners first reported a position in UTHR in Q1 2014 and held it in 4 quarters. The position peaked at $3.18M in Q1 2014. 398 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

  • Santa Fe Partners reported no remaining United Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 13,135 United Therapeutics shares in Q1 2016, an estimated $2.06M.
  • Santa Fe Partners first reported a position in United Therapeutics in Q1 2014 and held it in 4 quarters.
  • Santa Fe Partners's United Therapeutics position peaked at $3.18M in Q1 2014.
  • 398 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.